BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24038938)

  • 1. Association of TP53 polymorphisms on the risk of Wilms tumor.
    Andrade RC; Cardoso LC; Ferman SE; Faria PS; Seuánez HN; Achatz MI; Vargas FR
    Pediatr Blood Cancer; 2014 Mar; 61(3):436-41. PubMed ID: 24038938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral wilms tumor with TP53-related anaplasia.
    Popov SD; Vujanic GM; Sebire NJ; Chagtai T; Williams R; Vaidya S; Pritchard-Jones K
    Pediatr Dev Pathol; 2013; 16(3):217-23. PubMed ID: 23387809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.
    Ooms AH; Gadd S; Gerhard DS; Smith MA; Guidry Auvil JM; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Huff V; Dome JS; Chi YY; Tian J; Geller JI; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Walz AL; van den Heuvel-Eibrink MM; de Krijger RR; Ross N; Gastier-Foster JM; Perlman EJ
    Clin Cancer Res; 2016 Nov; 22(22):5582-5591. PubMed ID: 27702824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
    Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
    Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
    Rakheja D; Khokhar S; Mitui M; Cost NG
    Pediatr Dev Pathol; 2012; 15(4):286-92. PubMed ID: 22483234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
    Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
    Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
    Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
    J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
    Maschietto M; Williams RD; Chagtai T; Popov SD; Sebire NJ; Vujanic G; Perlman E; Anderson JR; Grundy P; Dome JS; Pritchard-Jones K
    PLoS One; 2014; 9(10):e109924. PubMed ID: 25313908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
    Lahoti C; Thorner P; Malkin D; Yeger H
    Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
    Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.
    Hernández S; López-Knowles E; Lloreta J; Kogevinas M; Jaramillo R; Amorós A; Tardón A; García-Closas R; Serra C; Carrato A; Malats N; Real FX
    Clin Cancer Res; 2005 Aug; 11(15):5444-50. PubMed ID: 16061860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expression in Wilms' tumor: a possible role as prognostic factor.
    Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
    Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of p53 in Wilms' tumors.
    Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
    Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
    Bardeesy N; Beckwith JB; Pelletier J
    Cancer Res; 1995 Jan; 55(2):215-9. PubMed ID: 7812946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.